| New Procedure Treats First Patient in a Clinical Trial - Renal Business Today |
|
|
Renal Business Today Vessix Vascular, Inc., a developer of novel percutaneous radiofrequency (RF) balloon catheter technology, announced today initial patient treatments in the international multi-center REDUCE-HTN renal denervation clinical study for uncontrolled |